Strain-Specific Protective Effect of the Immunity Induced by Live Malarial Sporozoites under Chloroquine Cover

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Wijayalath, Wathsala ^a   Cheesman, Sandra ^b   Tanabe, Kazuyuki ^c   Handunnetti, Shiroma ^d   Carter, Richard ^b   Pathirana, Sisira ^a  

^a UNIVERSITY OF COLOMBO   (Sri Lanka)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c OSAKA UNIVERSITY   (Japan)

^d UNIVERSITY OF COLOMBO   (Sri Lanka)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; CIRCUMSPOROZOITE PROTEIN; LIVE VACCINE; PRIMAQUINE; SPOROZOITE VACCINE;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOPHELES; ANOPHELES TESSELLATES; ARTICLE; CONTROLLED STUDY; CSP GENE; GENE; GENETIC STRAIN; HAPLORHINI; IMMUNIZATION; INFECTION PREVENTION; MALARIA; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITEMIA; PLASMODIUM CYNOMOLGI; PLASMODIUM CYNOMOLGI INFECTION; PROVOCATION TEST; PYROSEQUENCING; QUANTITATIVE ASSAY; SINGLE NUCLEOTIDE POLYMORPHISM; SPOROZOITE; STRAIN DIFFERENCE;

ANIMALS; ANOPHELES; ANTIMALARIALS; CHLOROQUINE; FEMALE; GENES, PROTOZOAN; IMMUNITY, ACTIVE; MACACA; MALARIA; MALARIA VACCINES; PARASITEMIA; PLASMODIUM CYNOMOLGI; POLYMORPHISM, SINGLE NUCLEOTIDE; SPOROZOITES; STATISTICS, NONPARAMETRIC; VACCINES, LIVE, UNATTENUATED;

MACACA SINICA; PLASMODIUM CYNOMOLGI; RODENTIA;

EID: 84866661277     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045861     Document Type: Article

References (25)

1. Good MF, Doolan DL, (2010) Malaria Vaccine Design: Immunological Considerations. Immunity 33: 555-566.
2. Hoffman SL, Billingsley PF, James E, Richman A, Loyevsky M, et al. (2010) Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria. Hum Vaccin 6: 97-106.
3. Vaughan AM, Wang R, Kappe SH, (2010) Genetically engineered, attenuated whole-cell vaccine approaches for malaria. Hum Vaccin 6: 107-113.
4. Belnoue E, Costa FT, Frankenberg T, Vigario AM, Voza T, et al. (2004) Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J Immunol 172: 2487-2495.
5. Roestenberg M, McCall M, Hopman J, Wiersma J, Luty AJF, et al. (2009) Protection against a malaria challenge by sporozoite inoculation. New Engl J Med 361: 468-477.
6. Good MF, (2005) Vaccine-induced immunity to malaria parasites and the need for novel strategies. Trends Parasitol 21: 29-34.
7. Renia L, (2008) Protective immunity against malaria liver stage after vaccination with live parasites. Parasite 15: 379-383.
8. Escalante AA, Grebert HM, Isea R, Goldman IF, Basco L, et al. (2002) A study of genetic diversity in the gene encoding the circumsporozoite protein (CSP) of Plasmodium falciparum from different transmission areas-XVI. Asembo Bay Cohort Project. Mol Biochem Parasitol 125: 83-90.
9. Cui L, Mascorro CN, Fan Q, Rzomp KA, Khuntirat B, et al. (2003) Genetic diversity and multiple infections of plasmodium vivax malaria in western Thailand. Am J Trop Med Hyg 68: 613-619.
10. Leclerc MC, Menegon M, Cligny A, Noyer JL, Mammadov S, et al. (2004) Genetic diversity of Plasmodium vivax isolates from Azerbaijan. Malaria Journal 3: 40 doi:10.1186/1475-2875-3-40.
11. Farooq U, Malla N, Dubey ML, (2009) Genetic polymorphism in msp-2, ama-1 and csp genes in Plasmodium falciparum field isolates from north and north-western India. J Vector Borne Dis 46: 109-116.
12. Clyde DF (1990) Immunity to falciparum and vivax malaria induced by irradiated sporozoites: a review of the University of Maryland studies, 1971-75. Bull. World Health Organ 68 (suppl.): 9-12.
13. Rieckmann KH (1990) Human immunization with attenuated sporozoites. Bull. World Health Organ 68 (suppl.): 13-16.
14. Luke TC, Hoffmann SL, (2003) Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine. J Exp Biol 206: 3803-3808.
15. Millet P, Kamboj KK, Cochrane AH, Collins WE, Broderson JR, et al. (1989) In-vitro exoerythrocytic development of Plasmodium cynomolgi bastianellii: inhibitory activity of monoclonal antibodies against sporozoites of different P. cynomolgi strains and of P. knowlesi. Parasit Immunol 11: 223-230.
16. Culleton RL, Inoue M, Reece SE, Cheesman S, Carter R, (2011) Strain-specific immunity induced by immunization with pre-erythrocytic stages of Plasmodium chabaudi. Parasite Immunol 33: 73-78.
17. Wijayalath WAWK, Cheesman S, Rajakaruna J, Handunnetti SM, Carter R, et al. (2008) Evidence for strain-specific protective immunity against blood-stage parasites of Plasmodium cynomolgi in toque monkey. Parasite Immunol 30: 630-636.
18. Wijayalath WAWK (2010) Studies on relapses and strain-specific protective immunity in Plasmodium cynomolgi infections in toque monkey (Macaca sinica). (PhD dissertation) Colombo: Faculty of Medicine, University of Colombo.
19. Abeywickreme W (1995) Immune responses to malaria parasites in mosquitoes (PhD dissertation). Liverpool: Liverpool School of Tropical Medicine.
20. Peters W, (1974) Recent advances in antimalarial chemotherapy and drug resistance. Adv Parasitol 12: 69-114.
21. Tanabe K, Escalante A, Sakihama N, Honda M, Arisue N, et al. (2007) Recent independent evolution of msp1 polymorphism in Plasmodium vivax and related simian malaria parasites. Mol Biochem Parasitol 156: 74-79.
22. Cheesman S, Creasey A, Degnan K, Kooij T, Afonso A, et al. (2007) Validation of Pyrosequencing™ for accurate and high throughput estimation of allele frequencies in malaria parasites Mol Biol Parasitol. 152: 213-219.
23. Yayon A, Vande Waa JA, Yayon M, Geary TG, Jensen JB, (1983) Stage-dependent effects of chloroquine on Plasmodium falciparum in vitro. J Protozool 30: 642-647.
24. Martinelli A, Cheesman S, Hunt P, Culleton R, Raza A, et al. (2005) A genetic approach to the de novo identification of targets of strain-specific immunity in malaria parasites. Proc Natl Acad Sci USA 102: 814-819.
25. Herrera S, Gomez A, Vera O, Vergara J, Valderrama-Aquirre A, et al. (2005) Antibody response to Plasmodium vivax antigens in fy-negative individuals from the colombian pacific coast. Am J Trop Med Hyg 73: 44-49.